General Pharmacology: The Vascular System
Volume 26, Issue 3, May 1995, Pages 489-494
General paperEffects of chronic treatments with sm-9018, a potential atypical neuroleptic, on behavioral dopaminergic and serotonergic sensitivities in rats
References (22)
Relationship of the actions of neuroleptic drugs to the pathophysiology of tardive dyskinesia
Int. Rev. Neurobiol.
(1979)- et al.
Pharmacological actions of SM-9018, a new neuroleptic drug both potent 5-hydroxytryptamine2 and dopamine2 antagonistic actions
Jpn. J. Pharmac.
(1990) - et al.
Binding profile of SM-9018, a novel antipsychotic candidate
Jpn. J. Pharmac.
(1990) - et al.
Behavioral aspects of serotonin-dopamine interaction in the monkey
Eur. J. Pharmac.
(1985) - et al.
Evaluation of bradykinesia induction by SM-9018, a novel 5-HT2 and D2 receptor antagonist, using the mouse pole-test
Pharmac. Biochem. Behav.
(1994) - et al.
Effects of acute and chronic treatments with clozapine and haloperidol on serotonin (5-HT2) and dopamine (D2) receptors in the rat brain
Brain Res.
(1989) - et al.
Effects of drugs influencing central serotonergic mechanisms on haloperidol-induced catalepsy
Psychopharmacology
(1979) - et al.
Neuroleptic-induced extrapyramidal side effects: clinical perspectives with ritanserin (R 55667), a new selective 5-HT2 receptor blocking agent
Curr. Ther. Res.
(1986) - et al.
Effect of serotonin antagonism in schizophrenia: a pilot study with setoperone
Psychopharmacology
(1985) Pharmacology of fluperlapine compared with clozapine
Arzneimittelforschung
(1984)
Chronic treatment with dopamine receptor antagonists: Behavioral and pharmacologic effects on D1 and D2 dopamine receptors
J. Neurosci.
(1988)
Cited by (9)
Atypical antipsychotic properties of blonanserin, a novel dopamine D<inf>2</inf> and 5-HT<inf>2A</inf> antagonist
2010, Pharmacology Biochemistry and BehaviorChronic haloperidol administration does not block acute nicotine-induced improvements in radial-arm maze performance in the rat
1997, Pharmacology Biochemistry and BehaviorEffects of subchronic treatments with SM-9018, a novel 5-HT<inf>2</inf> and D<inf>2</inf> antagonist, on dopamine and 5-HT receptors in rats
1995, Progress in Neuropsychopharmacology and Biological PsychiatryPerospirone: Sumitomo Pharmaceuticals
2002, Current Opinion in Investigational Drugs
Copyright © 1995 Published by Elsevier Inc.